Overview

DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery

Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy and safety of Dextenza for the treatment of postoperative pain and inflammation following vitreo-retinal surgery
Phase:
Phase 4
Details
Lead Sponsor:
Patrick R. Oellers, MD
Collaborator:
Ocular Therapeutix, Inc.
Treatments:
Prednisolone